Academic literature on the topic 'Produits sanguins labiles'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Produits sanguins labiles.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Produits sanguins labiles":
Muller, Jean-Yves. "Transfusion sanguine : produits sanguins labiles." EMC - Hématologie 1, no. 1 (January 2006): 1–26. http://dx.doi.org/10.1016/s1155-1984(03)26726-1.
Poullin, Pascale, and Patrice Lefevre. "Produits sanguins labiles." EMC - Anesthésie-Réanimation 1, no. 1 (January 2004): 1–10. http://dx.doi.org/10.1016/s0246-0289(03)00097-5.
Souied, F., and F. Morin. "Produits sanguins labiles." EMC - Anesthésie-Réanimation 10, no. 2 (April 2013): 1–13. http://dx.doi.org/10.1016/s0246-0289(12)57418-9.
Hermine, O., B. Lassale, P. Morel, C. M. Samama, G. Folléa, M. Monsellier, S. Noël, J. D. Tissot, and J. J. Lefrère. "Besoins, prescriptions et sécurité des produits sanguins labiles ; autosuffisance en produits sanguins labiles." Transfusion Clinique et Biologique 21, no. 3 (June 2014): 120–31. http://dx.doi.org/10.1016/j.tracli.2014.01.002.
Lalande, Valérie, and Rachid Djoudi. "Contrôles bactériologiques des produits sanguins labiles." EMC - Biologie Médicale 1, no. 1 (January 2006): 1–8. http://dx.doi.org/10.1016/s2211-9698(06)76186-6.
Folléa, G., P. Hervé, G. Andreu, J. M. Bidet, D. Boudard, B. Dazey, L. Noël, and Y. Piquet. "Atténuation virale des produits sanguins labiles." Transfusion Clinique et Biologique 3, no. 2 (January 1996): 113–23. http://dx.doi.org/10.1016/s1246-7820(96)80027-9.
Lefrère, J. J., G. Andreu, C. Barisien, P. Bierling, B. Danic, P. Morel, T. Peyrard, T. Schneider, and J. Y. Muller. "Transfusion sanguine (I). Organisation, bases immunologiques et produits sanguins labiles." EMC - Hématologie 7, no. 3 (August 2012): 1–18. http://dx.doi.org/10.1016/s1155-1984(12)56112-1.
Wautier, J. L. "Indications des transfusions de produits sanguins labiles." Transfusion Clinique et Biologique 12, no. 1 (February 2005): 56–58. http://dx.doi.org/10.1016/j.tracli.2004.11.001.
BUSSEL, A., J. GEROTA, J. CAVALIER, M. MASSE, W. WALLER, and M. BIDET. "Déplétion en leucocytes des produits sanguins labiles." Revue Francaise de Transfusion et Immuno-hématologie 30, no. 2 (May 1987): 109–12. http://dx.doi.org/10.1016/s0338-4535(87)80155-1.
Cabaud, J. J. "Audit des dépôts de produits sanguins labiles." Transfusion Clinique et Biologique 7 (June 2000): 75s—79s. http://dx.doi.org/10.1016/s1246-7820(00)80022-1.
Dissertations / Theses on the topic "Produits sanguins labiles":
Mathoulin-Pelissier, Simone. "Utilisation des produits sanguins labiles en France : apport de l'épidémiologie." Bordeaux 2, 2002. http://www.theses.fr/2002BOR28956.
SANDID, IMAD. "Analyse des criteres de qualite des produits sanguins labiles homologues." Strasbourg 1, 1994. http://www.theses.fr/1994STR15076.
Perez, Paul. "Epidémiologie des contaminations bactériennes liées à la transfusion de produits sanguins labiles." Bordeaux 2, 2000. http://www.theses.fr/2000BOR28752.
This thesis illustrates the contribution of the epidemiologic approach to transfusion and haemovigilance, a public health surveillance system. Transfusion-refated bacterial contamination (TRBC) is the first cause of infection related to transfusion. Limitation of knowledge indicated the need for studies. The case-control study on TRBC within the haemovigilance network (Bacthem) was based on the inclusion of TRCB among all suspected cases notified in France during two years. TRBC was letal for 15 % of 41 cases, all related to Gram negative rods. Transfusion of platelet concentrates, and of red cells when the recipient had pancytopenia, were strongly associated with TRBC risk. Suggested determinants were recipient treatment by potent immunosuppressive drugs, LBP shelf-life and numerous previous donations in the donor. The study of diversion of the first 15 mL of whole-blood donation suggests that this collection procedure may reduce donation contamination rates from 2. 2 to 0. 6 %. Contamination determinants were the collecting blood bank, the donor's age above 35 and the lack of repetition of the cleaning stage of antisepsis. Results open avenues for research for preventing TRBC. Excluding the first millilitres and improving the phlebotomy site preparation may reduce donation contamination rates. Indicating low-risk LBP in high risk recipients should be considered. Integrating epidemiology should lead to improvements of the haemovigilance system
Dufour-Gaume, Frédérique. "Enjeux, préparation et évaluation de produits sanguins labiles innovants adaptés aux blessés de guerre." Electronic Thesis or Diss., université Paris-Saclay, 2023. http://www.theses.fr/2023UPASQ076.
War casualties associate multiple injuries with shock hemorrhage. Despite the therapeutic progress of recent years, hemorrhage is the leading cause of preventable deaths and secondary multiple organ failure can lead to vital and functional prognosis. Management of war-injured patients based on damage control resuscitation and massive transfusion of whole blood reduced considerably the number of deaths. Nevertheless, during foreign operations whole blood is sometimes lacking because of logistic limitations and massive casualties. Modified blood products that are free from constraints could help war-injured patients to survive. To achieve this objective, we developed two French hyper-concentrated lyophilized plasmas with (FLYP-H/LP) or not (FLYP-H) lyophilized platelets. The production of these products is of a high quality. FLYP-H and FLYP-H/LP are high protein products, especially albumin, which confer them a hyperosmolarity twice that of plasma. In FLYP-H/LP, platelets were lysed during the manufacturing process and liberated high quantities of coagulation factors, such as fibrinogen. The therapeutic effects of FLYP-H and FLYP-H/LP were evaluated thanks to our war-injured porcin model. Statistical analysis highlighted the beneficial effects of FLYP-H and FLYP-H/LP on cardiovascular function and hemostasis. These results open the door to more analysis but on human FLYP-H and FLYP-H/LP
Rigoureau, Bertrand. "Le matériel à usage unique dans la transfusion sanguine : l'évolution de sa contribution dans l'amélioration de la qualité des produits sanguins labiles." Bordeaux 2, 1997. http://www.theses.fr/1997BOR2P102.
Didier, Anne. "Facteurs prédictifs de consommation en produits sanguins labiles : analyse rétrospective sur 166 transplantations hépatiques orthotopiques." Bordeaux 2, 1999. http://www.theses.fr/1999BOR23073.
Morel, Pascal. "Maladies infectieuses transmises par la transfusion sanguine, à propos de la contamination bactérienne des produits sanguins labiles : analyse des événements et étude comparative des méthodes de détection." Besançon, 2002. http://www.theses.fr/2002BESAA001.
Nyitchokeu-Biamou, Alain Didelle. "La consommation des produits sanguins à l'hôpital de Marmande." Bordeaux 2, 1998. http://www.theses.fr/1998BOR2M042.
Book chapters on the topic "Produits sanguins labiles":
Bourgeon-Ghittori, Irma, and Edith De Meyer. "Transfusion de produits sanguins labiles." In Références en réanimation. Collection de la SRLF, 195–203. Paris: Springer Paris, 2014. http://dx.doi.org/10.1007/978-2-8178-0503-0_34.
Garin, L., and O. Guillemaut. "Transfusions de produits sanguins labiles." In Réanimation et urgences, 395–403. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-287-99129-5_27.
Marc, Bernard, Patrick Miroux, Isabelle Piedade, Raphaelle Benveniste, Charles Jeleff, and Dominique Pateron. "Produits sanguins labiles." In Guide infirmier des urgences, 551–53. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-05637-6.50127-6.
Lefrère†, Jean-Jacques, and Philippe Rouger. "Utilisation des produits sanguins labiles." In Transfusion sanguine, 189–260. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74496-9.00005-2.
Lefrère, Jean-Jacques, and Philippe Rouger. "Utilisation des produits sanguins labiles." In Transfusion sanguine, 167–226. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-71523-5.00005-4.
HALLOUËT, Pascal, Jérôme EGGERS, and Evelyne MALAQUIN-PAVAN. "Pose et surveillance de transfusion (produits sanguins labiles)." In Fiches de soins infirmiers, 559–73. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74334-4.50082-4.